Skip to main navigation
Skip to search
Skip to main content
University College Cork Home
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Search by expertise, name or affiliation
AHUS caused by complement dysregulation: New therapies on the horizon
Aoife M. Waters
, Christoph Licht
University College London
Great Ormond Street Hospital for Children NHS Foundation Trust
University of Toronto
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'AHUS caused by complement dysregulation: New therapies on the horizon'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Complement Factor H
100%
Atypical Hemolytic Uremic Syndrome
80%
Alternative Complement Pathway C3 C5 Convertase
40%
Eculizumab
40%
Complement Factor I
40%
Membrane Cofactor Protein
40%
Diseases
20%
Clinical Trial
20%
End Stage Renal Disease
20%
Glycoprotein
20%
Kidney Function
20%
Kidney Transplantation
20%
Monoclonal Antibody
20%
Autoantibody
20%
Antithrombotic
20%
Synapsin I
20%
Thrombomodulin
20%
Plasma Exchange
20%
Complement Component C5a
20%
Complement Component C3a
20%
Complement Regulator
20%
Plasma Transfusion
20%
Pharmacology, Toxicology and Pharmaceutical Science
Complement Factor H
100%
Hemolytic Uremic Syndrome
80%
Membrane Cofactor Protein
40%
Complement Factor I
40%
Alternative Complement Pathway C3 C5 Convertase
40%
Eculizumab
40%
Clinical Trial
20%
Diseases
20%
Monoclonal Antibody
20%
Glycoprotein
20%
Anticoagulant Agent
20%
End Stage Renal Disease
20%
Autoantibody
20%
Complement Component C5a
20%
Synapsin I
20%
Complement Component C3a
20%
Thrombomodulin
20%